Patients with MDD exhibit significantly higher triglyceride levels, which correlate with worse functional impairment scores.

Treatment with GLP-1 RAs for T2D and obesity is independently associated with an increased risk for osteoporosis, gout, and osteomalacia.

Current smoking in GD is linked to higher TRAb levels, increased odds of orbitopathy, and higher 12-month relapse risk after drug withdrawal.

Although the Graves disease treatment landscape remains challenging, emerging therapies could shift existing treatment ...

Adults with osteoporosis who receive denosumab vs bisphosphonates may have a lower long-term risk of developing knee osteoarthritis.

Polygenic growth scores help identify fetuses at risk for LGA birth weight, particularly in mothers with a BMI of 35 or higher.

Oral semaglutide reduces risk for heart failure events among patients with T2D and preexisting heart failure, according to the SOUL trial.

Prepregnancy parental overweight or obesity is associated with increased odds of offspring MASLD in adulthood.

Severe hypothyroidism is associated with a high burden of systolic/diastolic ventricular dysfunction and myocardial deformation abnormalities.

Postmenopausal obesity increases ER-positive breast cancer risk, particularly in non-HRT users, while premenopausal overweight may lower risk.

Both low and high levels of body roundness were linked to greater osteoarthritis risk among middle- and older-aged adults.

Guidelines are presented for supporting structured and effective transition of endocrine conditions from pediatric to adult health services.